Works matching IS 15228517 AND DT 2015 AND VI 17 AND IP 5


Results: 21
    1
    2
    3

    Highlights from the Literature.

    Published in:
    Neuro-Oncology, 2015, v. 17, n. 5, p. 636, doi. 10.1093/neuonc/nov056
    By:
    • Wick, Wolfgang;
    • Soffetti, Riccardo;
    • Aldape, Kenneth;
    • Mansouri, Sheila;
    • Huse, Jason
    Publication type:
    Article
    4

    Society news.

    Published in:
    Neuro-Oncology, 2015, v. 17, n. 5, p. 767, doi. 10.1093/neuonc/nov055
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.

    Published in:
    Neuro-Oncology, 2015, v. 17, n. 5, p. 708, doi. 10.1093/neuonc/nou356
    By:
    • Nabors, L. Burt;
    • Fink, Karen L.;
    • Mikkelsen, Tom;
    • Grujicic, Danica;
    • Tarnawski, Rafal;
    • Do Hyun Nam;
    • Mazurkiewicz, Maria;
    • Salacz, Michael;
    • Ashby, Lynn;
    • Zagonel, Vittorina;
    • Depenni, Roberta;
    • Perry, James R.;
    • Hicking, Christine;
    • Picard, Martin;
    • Hegi, Monika E.;
    • Lhermitte, Benoit;
    • Reardon, David A.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.

    Published in:
    Neuro-Oncology, 2015, v. 17, n. 5, p. 697, doi. 10.1093/neuonc/nou303
    By:
    • Green, Adam L.;
    • Ramkissoon, Shakti H.;
    • McCauley, Dilara;
    • Jones, Kristen;
    • Perry, Jennifer A.;
    • Hsu, Jessie Hao-Ru;
    • Ramkissoon, Lori A.;
    • Maire, Cecile L.;
    • Hubbell-Engler, Benjamin;
    • Knoff, David S.;
    • Shacham, Sharon;
    • Ligon, Keith L.;
    • Kung, Andrew L.
    Publication type:
    Article
    19
    20
    21